MENU
VRDN
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Viridian Therapeutics (VRDN) Ownership - Who owns Viridian Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.78B
P/E Ratio
N/A
Total Cash
571.37M
Projected Growth
N/A
Total Debt
20.96M
Revenue
288K
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash/Share
7.48
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
VRDN
Capitalization
1.78B
P/E Ratio
N/A
Risk (Beta)
0.88
Dividend Yield
N/A
Total Cash
571M
Total Cash/Share
7.48
Total Debt
21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
288K
ROE
N/A
Book Value
330M
P/B Ratio
5.27
Cash Flow
N/A
Earnings
-4.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
639K
Current Ratio
15.82
Current Revenue Per Employee
765.96
Dividends Per Share - Security
N/A
EBITDA
-224.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
8.47
Revenue To Assets
-48.67
Shares Held By Institutions
1.51B
Shares Outstanding - Current
76.4M
Total Liabilities
56.3M
Total Volume MTD
N/A
Value
-1
Gain YTD
9.229
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com